Products 2025: Positive Airway Pressure & Sleep Therapy
RT takes a look at positive airway pressure interfaces, masks, and sleep therapy devices from Cadwell, Mercury Medical, and Philips.
Category: Sleep Apnea
Sleep Apnea
Latest
Products 2025: Positive Airway Pressure & Sleep Therapy
RT takes a look at positive airway pressure interfaces, masks, and sleep therapy devices from Cadwell, Mercury Medical, and Philips.
Read More
Parental Engagement Tied to Better Pre-teen Sleep
Strong family relationships and high parental engagement are among the aspects of social connectedness that are associated with sufficient sleep duration in pre-teen children.
Read More
Poor Sleep Can Be Result of Relationship Insecurity
Poor sleep quality is related to relationship insecurity, which moderates the effect of sleep quality on daily feelings of jealousy, according to a new study presented at Sleep 2025.
Read More
Sleep Docs Prefer CPAP for Comorbid Obesity and Sleep Apnea, Patients Prefer Drugs
Sleep medicine professionals favor CPAP therapy to treat comorbid obesity and obstructive sleep apnea, while patients lean toward treatment with weight loss medication tirzepatide (Zepbound).
Read More
Oral Microbiome Diversity Linked to Long Sleep Duration in Teens, Young Adults
Oral microbiome diversity is positively associated with long sleep duration among teenagers and young adults, according to a new study to be presented at Sleep 2025.
Read More
Antidepressants That Suppress REM Sleep Improve ALS Survival
Antidepressants that suppress REM sleep are associated with improved survival in people with amyotrophic lateral sclerosis (ALS), according to research at ATS 2025.
Read More
Climate Change Increases Sleep Apnea Severity
Under the most likely climate change scenarios, the societal burden of obstructive sleep apnea is expected to double in most countries over the next 75 years.
Read More
Apnimed Pulse Oximeter Can Monitor OSA Treatment Response
A wearable pulse oximeter and connected software platform from Apnimed show promise for monitoring obstructive sleep apnea (OSA) and other sleep-related breathing diseases.
Read More
Resmed Launches NightOwl Home Sleep Test
Resmed’s NightOwl is a disposable home sleep test that uses a fingertip sensor to record up to 10 nights of sleep data and transmitting it to clinicians via the user’s smartphone.
Read More
Screen Time Linked to Sleep Disruptions, Depression in Teens
Excessive screen time in adolescents disrupts sleep, increasing the risk of depression—especially among girls.
Read More
Adenotonsillectomy Improved Pediatric Sleep-disordered Breathing
Adenotonsillectomy was tied to a 32% reduction in medical visits and a 48% reduction in prescription use among children with mild sleep-disordered breathing.
Read More
Daytime Sleepiness Tied to Greater Dementia Risk for Female Seniors
A study published in Neurology found that women in their 80s who experienced increasing daytime sleepiness over five years had double the risk of developing dementia.
Read More
CPAP Reduces Heart-related Mortality Up to 55%
A worldwide study of over one million patients with sleep apnea provides the strongest evidence to date that CPAP therapy not only alleviates OSA symptoms but can also prolong life.
Read More
54% of Americans Want Daylight Saving Time Ended
As the annual “spring forward” to observe daylight saving time approaches on March 9, new Gallup polling data reveals a majority of Americans want to eliminate the practice.
Read More
Global Sleep Study Reveals the Impact of Poor Sleep
Results from ResMed’s fifth annual Global Sleep Study reveal the toll that poor sleep takes on health, work, and relationships.
Read More
Diabetic Patients With Sleep Apnea Face Higher Death Risk
Diabetic patients with severe obstructive sleep apnea showed a 58% increase in all-cause mortality.
Read More
Patch-based Home Sleep Test Found Comparable to In-Lab PSG
A study demonstrates comparable performance between the wireless, patch-based sleep test system and in-lab polysomnography for sleep staging and respiratory event detection.
Read More
FDA Greenlights Phase 2 Trial of Drug Targeting OSA and Hypertension
The trial will evaluate the drug’s potential to reduce upper airway obstruction and nocturnal hypertension in patients with moderate-to-severe OSA.
Read More
Optical Imaging Could Bring Precision to Sleep Apnea Diagnosis
Optical imaging combines with computational fluid dynamics to provide precise 3D reconstructions of the upper airway, improving the detection and localization of obstructive sleep apnea.
Read More
AASM: Zepbound Approval for OSA a ‘Positive Development’
The AASM issued a statement in response to the FDA’s approval of Zepbound for OSA patients with obesity, highlighting its potential as a new treatment option while cautioning about its limitations and the importance of sustained weight loss.
Read More
Encrypted AI System Spots Sleep Apnea Without Privacy Risks
A new AI technique using fully homomorphic encryption achieved 99.56% accuracy in detecting sleep apnea while safeguarding patient data.
Read More
FDA Approves Zepbound for Sleep Apnea Patients With Obesity
The FDA has approved Zepbound as the first prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity.
Read More
Sleep Apnea Linked to Increased Brain Growth
Sleep apnea may lead to increased brain growth in the hippocampus, which could have implications for memory and cognitive function.
Read More
Eli Lilly’s Mounjaro Doesn’t Need Separate Approval for Sleep Apnea, Says EMA
The EMA has determined that Mounjaro’s existing weight management approval includes its benefits for treating obstructive sleep apnea, eliminating the need for a separate application for an OSA indication.
Read More